Tiletamine/Zolazepam

23 adverse event reports submitted to the FDA

Important: Adverse event reports do not establish that a drug caused or contributed to the event. Consult your veterinarian before making treatment decisions.

Total Reports

Deaths Reported

3040.0%

Death Rate

Active Ingredients

Tiletamine/Zolazepam

Administration Routes

UnknownParenteralIntravenousIntramuscular

Species Affected

Dog 11

Cat 9

Horse 1

Pig 1

Sheep 1

Most Affected Breeds

Domestic Shorthair 8

Retriever - Labrador 3

Dog (unknown) 2

Rottweiler 1

Shar Pei 1

Tennessee Walking Horse 1

Pekingese 1

Domestic (unspecified) 1

Shepherd Dog - German 1

Pig (unknown) 1

Most Reported Reactions

Mydriasis 5

Lethargy (see also Central nervous system depression in 'Neurological') 4

Other abnormal test result NOS 4

Lack of efficacy - NOS 4

Fever 4

Vomiting 3

Ataxia 3

Death 3

Diarrhoea 2

Anorexia 2

Jaundice 2

Hypoproteinaemia 2

Outcome Breakdown

Recovered/Normal

10 (41.7%)

Ongoing

4 (16.7%)

Euthanized

4 (16.7%)

Outcome Unknown

3 (12.5%)

Died

3 (12.5%)

Source: FDA Center for Veterinary Medicine — Adverse Event Reports. Data reflects voluntary submissions and may not represent actual incidence rates.